Azathioprine-related myelosuppression in a patient homozygous for TPMT☆3A

被引：19

作者：

Budhiraja, Pooja ^{[1
]}

Popovtzer, Mordecai ^{[1
]}

机构：

[1] So Arizona Vet Affairs Hlth Care Syst, Tucson, AZ 85723 USA

来源：

NATURE REVIEWS NEPHROLOGY | 2011年 / 7卷 / 08期

关键词：

INFLAMMATORY-BOWEL-DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; THIOPURINE METHYLTRANSFERASE ACTIVITY; TRANSPLANT RECIPIENTS; TPMT; GENOTYPE; MERCAPTOPURINE; PHENOTYPE; PHARMACOGENETICS; 6-MERCAPTOPURINE;

D O I：

10.1038/nrneph.2011.74

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background. A 50-year-old man who had received a simultaneous pancreas and kidney transplant 9 years earlier developed pancytopenia 3 weeks after starting azathioprine therapy to treat worsening proteinuria suspected to be caused by sirolimus. Investigations. Laboratory tests, including complete blood counts, measurement of serum levels of vitamin B-12 and folate, liver function tests, virological assays, and thiopurine S-methyltransferase (TPMT) genotyping. Diagnosis. Severe myelosuppression as a consequence of azathioprine therapy in a patient homozygous for the TPMT(star)3A allele. Management. Discontinuation of azathioprine, treatment with an erythropoiesis-stimulating agent, red blood cell transfusions, filgrastim (a granulocyte colony-stimulating factor analogue) and folic acid.

引用

页码：478 / 484

页数：7

共 30 条

[11] Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine [J].

Evans, WE ;

Hon, YY ;

Bomgaars, L ;

Coutre, S ;

Holdsworth, M ;

Janco, R ;

Kalwinsky, D ;

Keller, F ;

Khatib, Z ;

Margolin, J ;

Murray, J ;

Quinn, J ;

Ravindranath, Y ;

Ritchey, K ;

Roberts, W ;

Rogers, ZR ;

Schiff, D ;

Steuber, C ;

Tucci, F ;

Kornegay, N ;

Krynetski, EY ;

Relling, MV .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2293-2301

[12] Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients [J].

Karas-Kuzelicki, N. ;

Jazbec, J. ;

Milek, M. ;

Mlinaric-Rascan, I. .

LEUKEMIA, 2009, 23 (05) :971-974

[13] TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients [J].

Kurzawski, Mateusz ;

Dziewanowski, Krzysztof ;

Lener, Agnieszka ;

Drozdzik, Marek .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (05) :533-540

[14] Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis [J].

Langley, PG ;

Underhill, J ;

Tredger, JM ;

Norris, S ;

McFarlane, IG .

JOURNAL OF HEPATOLOGY, 2002, 37 (04) :441-447

[15] CONGENITAL THIOPURINE METHYLTRANSFERASE DEFICIENCY AND 6-MERCAPTOPURINE TOXICITY DURING TREATMENT FOR ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

LENNARD, L ;

GIBSON, BES ;

NICOLE, T ;

LILLEYMAN, JS .

ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (05) :577-579

[16] THIOPURINE PHARMACOGENETICS IN LEUKEMIA - CORRELATION OF ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY AND 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS [J].

LENNARD, L ;

VANLOON, JA ;

LILLEYMAN, JS ;

WEINSHILBOUM, RM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (01) :18-25

[17] Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis [J].

Osterman, MT ;

Kundu, R ;

Lichtenstein, GR ;

Lewis, JD .

GASTROENTEROLOGY, 2006, 130 (04) :1047-1053

[18] Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms [J].

Otterness, D ;

Szumlanski, C ;

Lennard, L ;

Klemetsdal, B ;

Aarbakke, J ;

ParkHah, JO ;

Iven, H ;

Schmiegelow, K ;

Branum, E ;

OBrien, J ;

Weinshilboum, R .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) :60-73

[19] Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells [J].

Panetta, JC ;

Evans, WW ;

Cheok, MH .

BRITISH JOURNAL OF CANCER, 2006, 94 (01) :93-100

[20] TPMT genotype screening for patients about to begin azathioprine treatment - A look at costs and potential benefits [J].

Provenzale, D ;

Onken, JE .

INFLAMMATORY BOWEL DISEASES, 2005, 11 (12) :1119-1120

← 1 2 3 →